To assess this relationship in vivo, we stained for CCL11 in control and ATX-deficient tumors and found greater CCL11 expression when ATX was inhibited, either constitutively or inducibly (Fig. 5d and Extended Data Fig. 4b), which was barely detectable in ATX-expressing tumor cells. The gene discussed is CCL11; the disease is neoplasm.